| Patent application number | Description | Published |
|---|
| 20090258891 | Macrocyclic Compounds As Antiviral Agents - The present invention relates to macrocyclic compounds of formula (I): wherein W, n, R | 10-15-2009 |
| 20100099695 | HCV NS3 Protease Inhibitors - The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use for treating or preventing HCV infections. | 04-22-2010 |
| 20100183551 | Macrocyclic Compounds As Antiviral Agents - A class of macrocyclic compounds of formula (I), wherein R | 07-22-2010 |
| 20100210581 | Nucleoside Derivatives as Inhibitors of Viral Polymerases - A class of nucleoside derivatives of formula (I), as defined herein, that are useful as inhibitors of RNA-dependent RNA viral replication and in particular HCV replication, are provided. Also provided are processes for the synthesis and use of such compounds for treating or preventing HCV infection. | 08-19-2010 |
| 20100298210 | HCV NS3 Protease Inhibitors - The present invention relates to macrocyclic compounds of formula (I) that are useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, their synthesis, and their use treating or preventing HCV infections. | 11-25-2010 |
